Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: WALL St. Conference

Car Charging Group, Inc. (CCGI) Starts Presentation at WALL ST. Conference

Car Charging Group is a provider of public electric vehicle (EV) charging services, enabling EV drivers to easily recharge at locations throughout the United States. The company is headquartered in Miami Beach, Florida, and is supported by offices in San … Continue reading

Posted in WALL St. Conference | Leave a comment

Sito Mobile Ltd. (SITO) Starts Presentation at WALL ST. Conference

Sito Mobile has developed a mobile engagement platform that enables brands, businesses and advertisers to increase awareness, loyalty and ultimately sales. The company’s subsidiary, SITO Mobile R&D IP, LLC, was recently granted a U.S. patent titled “Searching for Mobile Content.” … Continue reading

Posted in WALL St. Conference | Leave a comment

Sunvault Energy Corp. (SVLT) Starts Presentation at WALL ST. Conference

Sunvault Energy is focused on delivering cost-effective energy generation and energy storage to the residential and commercial solar industry by means of a seamless and novel integration of energy generation and storage. This technical approach is a first and has … Continue reading

Posted in WALL St. Conference | Leave a comment

China Recycling Corp. (CREG) Starts Presentation at WALL ST. Conference

China Recycling provides environmentally friendly waste-to-energy technologies to recycle a range of industrial byproducts for steel mills, cement factories and coke plants in China. Byproducts include heat, steam, pressure and exhaust to generate large amounts of lower-cost electricity and reduce … Continue reading

Posted in WALL St. Conference | Leave a comment

Cellceutix Corp. (CTIX) Starts Presentation at WALL ST. Conference

Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antimicrobial applications. Among numerous other compounds in the company’s portfolio is anti-cancer drug Kevetrin, which is currently in a phase 1 clinical trial at Harvard Cancer … Continue reading

Posted in WALL St. Conference | Leave a comment

VistaGen Therapeutics, Inc. (VSTA) Starts Presentation at WALL ST. Conference

VistaGen Therapeutics is developing innovative medicine for depression and diseases and conditions involving the central nervous system (CNS). The company’s AV-101 is a new generation orally available anti-depressant candidate entering phase 2 clinical development. Based on preclinical studies, AV-101 may … Continue reading

Posted in WALL St. Conference | Leave a comment

Lightlake Therapeutics, Inc. (LLTP) Starts Presentation at WALL ST. Conference

Leveraging its expertise in opioid antagonists, biopharmaceutical company Lightlake Therapeutics is building a platform of intranasal naloxone solutions to treat common addictions and related disorders. Lightlake has completed a phase 2 clinical trial to treat binge eating disorder and is … Continue reading

Posted in WALL St. Conference | Leave a comment

Implant Sciences Corp. (IMSC) Starts Presentation at WALL ST. Conference

Implant Sciences develops and manufactures advanced, proprietary detection technologies designed to counter and eliminate the threat of explosives and drugs. Implant Sciences has sold its commercial explosives trace detection (ETD) and drugs trace detection technologies to customers in more than … Continue reading

Posted in WALL St. Conference | Leave a comment

OWC Pharmaceutical Research Corp. (OWCP) Starts Presentation at WALL ST. Conference

OWC Pharmaceutical Research, via subsidiary One World Cannabis Ltd., is an Israel-based company founded in 2014 by a group of professionals with expertise in the field of medical cannabis (marijuana) treatment and medical cannabis regulatory affairs. The company’s Research Division … Continue reading

Posted in WALL St. Conference | Leave a comment